Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Animalcare GroupLSE:ANCR 76 FCF Yield % is 3.28 as of Jul. 17, 2026, which is 36% below its 10-year median of 5.12. GuruFocus rates LSE:ANCR with a GF Score™ of 76/100 and a GF Value™ of £2.56 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Animalcare Group ranks better than 66.43% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Animalcare Group FCF Yield % Related Terms
Animalcare Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for Animalcare Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:ANCR vs ZTS, UTHR, VTRS: FCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Animalcare Group FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Animalcare Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group (LSE:ANCR) has a FCF Yield % of 3.28 as of Jul. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Animalcare Group and its competitors. This is 36% below median its historical median of 5.12. Over the past decade, Animalcare Group's FCF Yield % has ranged from 0.40 to 11.89. According to the industry distribution chart, Animalcare Group ranks #338 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 33.6%.
Is Animalcare Group's FCF Yield % too high?
Animalcare Group's current FCF Yield % of 3.28 is 36% below median its 10-year median of 5.12. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 11.89. The Drug Manufacturers industry median FCF Yield % is 0.71. Animalcare Group's value of 3.28 is 362% above this industry median. Based on the distribution chart, Animalcare Group ranks #338 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Animalcare Group has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Animalcare Group's FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Animalcare Group ranks #338 out of 1007 companies for FCF Yield %. This puts Animalcare Group in the upper half of its industry. The industry median FCF Yield % is 0.71. Animalcare Group's value of 3.28 is 362% above this benchmark. Historically, Animalcare Group's own FCF Yield % has ranged from 0.40 to 11.89 over the past decade. While the company's 10-year median is 5.12 vs. the industry median of 0.71, Animalcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.71, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Animalcare Group's current FCF Yield % of 3.28 is 362% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Animalcare Group and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Animalcare Group's current FCF Yield % is 3.28, which is 36% below median its own 10-year median of 5.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Animalcare Group stock overvalued right now?
Based on GuruFocus' analysis, Animalcare Group (LSE:ANCR) is currently considered Modestly Overvalued. The stock's GF Value™ is £2.56, compared to a current price of £3.34 — trading 30.3% above its estimated fair value. The current FCF Yield % is 3.28, which is 36% below median its 10-year median of 5.12 and 362% above the Drug Manufacturers industry median of 0.71. Animalcare Group's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Animalcare Group (LSE:ANCR), the current FCF Yield % is 3.28 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Animalcare Group (LSE:ANCR) Overvalued in 2026?
Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued.
The current stock price of £3.34 is trading 30.3% above its estimated GF Value™ of £2.56.
GuruFocus considers Animalcare Group to be Modestly Overvalued.
Key valuation signals for LSE:ANCR:
FCF Yield %: 3.28 (36% below median its 10-year median of 5.12)
GF Value™: £2.56 vs. price of £3.34 (30.3% above fair value)
Industry Position: 362% above the Drug Manufacturers median (#338 of 1007)
No single metric tells the full story. See the LSE:ANCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
76GF Score
Get the complete analysis for LSE:ANCR
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:ANCR has been successfully added to your 
